Skip to main content
. 2021 Aug 11;3(5):100352. doi: 10.1016/j.jhepr.2021.100352

Table 1.

Overlapping and differing characteristics of hepatic encephalopathy in ALF and CLD.

NGVU disturbance ALF/CLD overlap ALF/CLD difference
Disturbed energy metabolism
  • Reduced cerebral blood flow impairs supply of oxygen and nutrients to the brain44,45

  • Increased cerebral lactate marks energy impairment41

  • Ammonia inhibits Krebs cycle enzymes28

  • Lactate is involved in cerebral oedema41,53

CLD: Deficient ketone body production in the cirrhotic liver, insufficient to compensate for glucose allocation to the immune system[46], [47], [48], [49]; Lactate elevation is inconsistent51,54
Blood-brain barrier disruption
  • Increased BBB permeability. Barrier integrity disturbed through tight junction disruption[59], [60], [61],[64], [65], [66]

  • Altered function of efflux transporters, particularly BCRP69,79,80

ALF: Barrier integrity disruption results in vasogenic brain oedema50,52; MMP9 mediates breakdown of tight junctions63,72,73
CLD: Evidence regarding BBB permeability, structure and tight junction alterations is inconsistent[67], [68], [69], [70]
Astrocyte swelling
  • Cerebral glutamine accumulates secondary to increased ammonia exposure43,51,54,[87], [88], [89]

  • AQP4 dysregulation renders astrocytes more susceptible to osmotic shifts51,65,[98], [99], [100], [101]

ALF: Cellular swelling results in clinically significant brain oedema50,52; Hyperactivation of the ion channels NKCC1 and SUR1 creates ionic imbalances across the cell membrane and attracts water into the cell[93], [94], [95]
CLD: Compensatory decrease of myoinositol and other osmolytes51,54,89; Low grade cerebral oedema of unclear clinical significance52
Oxidative stress CLD: Possible disconnect, with only systemic oxidative stress in the absence of cerebral oxidative stress68; Senescence only studied in vitro and in patients with CLD111,113,116
Neuroinflammation ALF: TGFβ1144 and bile acids124 can contribute to microglial activation in mouse models of ALF
Glymphatic clearance CLD: Decreased glymphatic clearance leads to neuroinflammation in BDL rats101,122

ALF, acute liver failure; AQP4, aquaporin 4; BBB, blood-brain barrier; BCRP, breast cancer resistance protein; BDL, bile duct ligated; CLD, chronic liver disease; MMP9, matrix metalloproteinase 9; NKCC1, Na-K-2Cl cotransporter 1; SUR1, sulfonylurea receptor-1; TGFβ1, transforming growth factor β1; TNF, tumour necrosis factor